VigilaMed Logo
Regulatory Intelligence

Manufacturing Impact Reports

Real compliance transformations with measurable outcomes. From cardiovascular implants to diagnostic equipment.

Ovation Medical logo

Ovation Medical

Class I

FDA Class I — Orthopedic Braces & Supports

Challenge

Ovation Medical's QMS was built entirely around EU MDR requirements and contained zero FDA-specific content. The FDA QMSR enforcement date of February 2, 2026, had already passed when they engaged VigilaMed. Their system scored just 31% compliant across 31 applicable requirements, with 16 gaps identified — 10 of which were rated Critical. An FDA inspector would have issued Form 483 observations on day one.

Approach

  • Conducted forensic gap analysis across 49 QMSR clauses covering 6 FDA CFR parts
  • Mapped all Class I exemptions (18 of 49 requirements exempt) to focus remediation on the 31 that still applied
  • Prioritised 9 remediation tasks using regulatory dependency mapping, starting with MDR reporting (21 CFR 803) and corrections and removals (21 CFR 806)
  • Rewrote complaint handling to link triage directly to FDA MDR reportability criteria under 820.198
  • Corrected record retention to FDA lifetime+2 years and aligned the quality manual, document matrix, and labeling references
  • Dual-verified every finding with a second independent VigilaMed assessor

Outcomes

34
Calendar days from opening meeting to full compliance — including the QMSR enforcement date passing mid-project
Zero
Major findings at project close. FDA Form 483 risk eliminated for all assessed areas
16 → 0
Compliance gaps closed. From 31% compliant to a clear, verified path to 100% across all 31 applicable requirements
Cover: Ovation Medical
We evaluated six companies, including two we'd worked with before. By the time VigilaMed came to the first meeting, they already knew what we needed and what we didn't.

— Kenji Watabe, VP Operations, Ovation Medical

Completed Ahead of Schedule
Chosen Over 5 Competitors
Led to Second Engagement

Terumo Aortic

Class III

Class III Cardiovascular Implants

Challenge

Complex complaints backlog for high-risk devices, extended complaint closure timelines threatening vigilance compliance.

Approach

  • Redesigned complaints triage process for risk-based prioritization
  • Implemented medical device reporting (MDR) workflow optimization
  • Trained complaints team on global regulations and the new process for complaint handling
  • Created cross-functional review process (R&D, Manufacturing, RA)

Outcomes

20%
Reduction in complaint closure timelines
Zero
Observations in subsequent regulatory audit
100%
On-time adverse event report submissions to MHRA, FDA, PMDA, TFTA, ANVISA and various EU member states

Biosil

Class II

Medical-Grade Silicone Devices

Challenge

Manual vigilance reporting, inconsistent complaints and adverse event reporting documentation

Approach

  • Established six sigma methodology to introduce process improvements
  • Updated SOP's, WI's and forms to document the process
  • Established KPI's for on time reporting and complaint closure

Outcomes

Increased
Complaint on time closure rate
100%
On time adverse event reporting to multiple regulatory authorities
Zero
Findings after 3 day vigilence audit by ANSM

Multi-Site Manufacturer

Class I & II

Surgical Instruments & Diagnostic Equipment

Challenge

4 manufacturing sites with inconsistent QMS and a CAPA system not working effectively

Approach

  • Standardized SOPs across all manufacturing locations
  • Introduced six sigma methodology to CAPA process
  • Created CAPA effectiveness verification process and KPI's
  • Cross site training provided

Outcomes

Unified
CAPA process across all 4 sites
Robust
Root cause analysis using six sigma tools
Decrease
Recurring and unnecessary CAPAS
Communication
Improved across all sites leading to CAPA actions being implemented more efficiently
VigilaMed

Regulatory Excellence for Device Manufacturers. Elite Quality & Regulatory consultancy specializing in ISO 13485, FDA compliance, and medical device manufacturing excellence.

ISO 13485:2016 Lead AuditorFDA 21 CFR Part 820 ExpertSix Sigma Yellow Belt10+ Years Manufacturing

© 2026 VigilaMed Ltd. All rights reserved. Serving Class I, II, and III device manufacturers across UK, EU, and US markets.